Primary Antibody Immunodeficiency and the Pregnant Patient
An overview of primary antibody immunodeficiency in pregnancy is presented. Indications for immunoglobulin replacement therapy (IGRT), dosing, and safety considerations are highlighted. Uses of immunizations and antimicrobial therapy are also discussed. In general, IGRT, both intravenous and subcutaneous, is considered safe in pregnancy.
Source: Immunology and Allergy Clinics of North America - Category: Allergy & Immunology Authors: Shouling Zhang, Charlotte Cunningham-Rundles Source Type: research